Tag: Inclisiran

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Inclisiran

Renaissance Technologies LLC Raises Stake in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Added to Collection on: 2018-09-24 00:18:45

Tags for this article:

Health care
Alnylam Pharmaceuticals
Therapeutic gene modulation
Pharmacology
Biotechnology
RNA interference
Inclisiran
Patisiran
Renaissance Technologies LLC
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Increased by Renaissance Technologies ...

Added to Collection on: 2018-10-01 18:43:55

Tags for this article:

Alnylam Pharmaceuticals
Therapeutic gene modulation
Biotechnology
Pharmaceutical companies
RNA interference
Life Sciences
Inclisiran
Price?earnings ratio
Renaissance Technologies LLC
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Lodge Hill Capital Raised Its Position in Amazon Com (AMZN) as Stock Declined; Alnylam ...

Added to Collection on: 2019-09-15 05:56:15

Tags for this article:

Companies
Computing
Alnylam Pharmaceuticals
Therapeutic gene modulation
Industry economics)
Amazon
NASDAQ
Ion
Inclisiran
West Capital Management Lp
Alnylam Pharma
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Novartis's big wager on RNAi approaches the finish line

Added to Collection on: 2020-11-25 15:30:45

Tags for this article:

Medical specialties
PCSK9 inhibitors
Companies
Life Sciences
Monoclonal antibodies
Inclisiran
RNA interference
Regeneron Pharmaceuticals
Alirocumab
Familial hypercholesterolemia
Novartis
PCSK9
United States

Click the tags to see associated articles and topics

View Article Details
FDA delays decision on Novartis cholesterol therapy

Added to Collection on: 2020-12-21 16:52:30

Tags for this article:

Health sciences
Health care
PCSK9 inhibitors
Life Sciences
Monoclonal antibodies
Novartis
Inclisiran
Alirocumab
Regeneron Pharmaceuticals
PCSK9
Pharmaceutical industry
Food and Drug Administration

Click the tags to see associated articles and topics

View Article Details
Alnylam Launches "Alnylam P5x25" Strategy for Planned Transition to a Top Five Biotech in Market ...

Added to Collection on: 2021-01-10 18:00:00

Tags for this article:

Branches of biology
Life Sciences
Biology
RNA
Gene expression
Molecular biology
Alnylam Pharmaceuticals
Therapeutic gene modulation
Small interfering RNA
Inclisiran
Lumasiran
Novartis
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
PCSK9 affects antitumor immunity

Added to Collection on: 2021-04-22 14:15:00

Tags for this article:

PCSK9 inhibitors
Monoclonal antibodies
Medical specialties
PCSK9
Drugs
Lipids
Evolocumab
Alirocumab
Low-density lipoprotein
Cholesterol
Inclisiran
Proprotein convertase
Xuhui Bao

Click the tags to see associated articles and topics

View Article Details
Homozygous Familial Hypercholesterolemia Market: Future Forecast Indicates a Growth Rate at a ...

Added to Collection on: 2021-06-15 16:52:30

Tags for this article:

Chemical compounds
Medical specialties
Health
PCSK9 inhibitors
Lipid metabolism disorders
Monoclonal antibodies
Sterols
Familial hypercholesterolemia
Alirocumab
PCSK9
Lipid-lowering agent
Inclisiran
Germany
Italy
Juxtapid
France
Japan
United States
United Kingdom
Evolocumab
Spain

Click the tags to see associated articles and topics

View Article Details
Pharmacists' Role in ASCVD Management: Integrating Inclisiran into Patient Care

Added to Collection on: 2024-09-04 21:55:04

Tags for this article:

Cardiology
Inclisiran
Small interfering RNA
Pharmacy
Low-density lipoprotein
Atherosclerosis
Adherence
Lipid profile
Cholesterol
Pharmacist
Statin
Coronary artery disease
Novartis

Click the tags to see associated articles and topics

View Article Details
PCSK9-Targeted Therapy Market Size to Hit USD 28.71 Billion by 2034

Added to Collection on: 2025-07-08 13:57:30

Tags for this article:

PCSK9 inhibitors
PCSK9
Alirocumab
Familial hypercholesterolemia
Inclisiran
Evolocumab
Verve PCSK9-inhibitor gene therapy
Hyperlipidemia
Sanofi
Regeneron Pharmaceuticals
Alnylam Pharmaceuticals
Low-density lipoprotein
CRISPR
United States

Click the tags to see associated articles and topics

View Article Details
Book a Demo